Skip to main content
AMSKY Technology Co.,Ltd. logo

AMSKY Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300521 ISIN · CNE1000027W7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2020-05-19 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300521

About AMSKY Technology Co.,Ltd.

https://www.amsky.com

AMSKY Technology Co., Ltd. specializes in the research, development, and manufacturing of industrial precision printing equipment. The company’s core product portfolio includes Computer-to-Plate (CTP) systems for the offset and flexographic printing sectors, utilizing advanced thermal and UV laser imaging technologies. Beyond traditional prepress solutions, AMSKY has expanded into industrial inkjet printing and additive manufacturing, specifically developing high-speed sand 3D printers for foundry applications. The company leverages proprietary expertise in multi-channel laser control, piezoelectric inkjet drive technology, and high-precision motion systems to provide digital transformation solutions for the global printing and manufacturing industries. Its products serve diverse markets, including commercial printing, packaging, and industrial casting.

Recent filings

Filing Released Lang Actions
关于筹划重大资产重组事项的一般风险暨复牌的提示性公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from a company regarding the planning of a major asset restructuring, including risks related to approvals, transaction suspension, asset valuation, performance commitments, and regulatory compliance. It mentions the resumption of trading after a suspension due to the restructuring plan. The document does not contain actual financial statements or detailed financial data but rather discusses the status, risks, and procedural steps of the proposed transaction. It is a typical risk disclosure and update announcement related to a major asset restructuring and trading resumption. The document length is under 5,000 characters and primarily serves as a notice to investors about the risks and status of the transaction and the resumption of trading. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-19 Chinese
独立董事关于公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is an independent director's pre-approval opinion on a major asset swap, share issuance, cash payment for asset purchase, and related party transaction. It references compliance with company law, securities law, stock exchange rules, and governance standards. The content is a formal opinion supporting the transaction and its submission to the board meeting. It is not a full financial report, earnings release, or regulatory filing but a governance-related document expressing independent director approval on a major transaction. This fits best under Board/Management Information (MANG) as it relates to board-level approval and management decisions on significant corporate actions.
2020-05-19 Chinese
关于所提供信息真实性、准确性和完整性的承诺函（五）
Regulatory Filings Classification · 95% confidence The document is a formal letter of commitment regarding the truthfulness, accuracy, and completeness of information provided in relation to a major asset restructuring involving the acquisition of 100% equity of another company. It includes legal commitments and compliance with regulatory bodies such as the China Securities Regulatory Commission and Shenzhen Stock Exchange. The document does not contain financial statements or detailed financial data but is a legal assurance related to a transaction. It is not a full report, audit, or announcement of voting results. It is best classified as a Regulatory Filing (RNS) because it is a compliance-related document that does not fit other specific categories.
2020-05-19 Chinese
关于所提供信息真实性、准确性和完整性的承诺函（一）
Regulatory Filings Classification · 95% confidence The document is a formal letter of commitment regarding the truthfulness, accuracy, and completeness of information provided in relation to a major asset restructuring involving the acquisition of 100% equity of another company. It includes legal assurances and responsibilities but does not contain financial statements, detailed financial data, or report analysis. The document is short (1017 characters) and serves as a legal attestation related to a transaction rather than a financial report or announcement of voting results. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a proxy solicitation or AGM material. The document is best classified as a Regulatory Filing (RNS) because it is a compliance-related attestation letter connected to a corporate transaction.
2020-05-19 Chinese
董事会关于公司股票价格波动未达到《关于规范上市公司信息披露及相关各方行为的通知》第五条相关标准的说明
Regulatory Filings Classification · 95% confidence The document is a statement from the board of directors of 爱司凯科技股份有限公司 regarding the company's stock price fluctuations and compliance with the China Securities Regulatory Commission's Notice on Regulating Information Disclosure and Related Parties' Behavior (2007). It analyzes stock price changes over a 20 trading day period before a major event and concludes no abnormal price fluctuations occurred. The document is a formal explanation or announcement related to regulatory compliance and stock price behavior, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. It is not a voting result, nor a capital change or share transaction. The document is best classified as a Regulatory Filing (RNS) because it is a regulatory compliance disclosure that does not fit other specific categories.
2020-05-19 Chinese
关于所提供信息真实性、准确性和完整性的承诺函（四）
Regulatory Filings Classification · 95% confidence The document is a formal letter of commitment regarding the truthfulness, accuracy, and completeness of information provided in relation to a major asset restructuring involving a share acquisition and cash payment. It includes legal assurances and obligations related to disclosure and compliance with regulatory bodies such as the China Securities Regulatory Commission and Shenzhen Stock Exchange. The document is not a financial report, audit, or earnings release, nor is it a presentation or announcement of voting results. It is a legal commitment letter related to a transaction, but it does not itself constitute a merger or acquisition filing, nor a proxy or solicitation statement. Given the nature of the document as a formal regulatory compliance and disclosure commitment, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory and compliance documents that do not fit other specific categories. The document length is short and it is not an announcement of a report publication, so RPA is not appropriate.
2020-05-19 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.